Literature DB >> 10594751

Antibodies against hair follicles are associated with alopecia totalis in autoimmune polyendocrine syndrome type I.

H Hedstrand1, J Perheentupa, O Ekwall, J Gustafsson, G Michaëlsson, E Husebye, F Rorsman, O Kämpe.   

Abstract

In the autosomal recessively inherited autoimmune polyendocrine syndrome type I (APS I) patients have autoantibodies directed against several endocrine and nonendocrine organs. Alopecia areata is present in about one-third of the patients and usually in the more severe forms, alopecia universalis or totalis. Sera from 39 patients with APS I, diluted 1:150, were used in indirect immunofluorescence staining of cryo-sections from normal human scalp. Two hair follicle staining patterns were observed. A cytoplasmic staining of the differentiating matrix, cuticle, and cortex keratinocytes in the anagen hair follicle was seen in five (13%) APS I sera. All these five patients had alopecia totalis, representing 63% of the eight patients with alopecia totalis (p < 0.0001). Furthermore, four (10%) of the APS I sera stained the nuclei of the melanocytes in the hair follicle. Two of these patients had vitiligo. None of 20 healthy control sera stained the keratinocyte cells or the melanocyte nuclei. These data show that many patients with APS I have high-titer autoantibodies directed against the anagen matrix, cuticle, and cortex keratinocytes and a melanocyte nuclear antigen, and also that the hair follicle keratinocyte staining is associated with alopecia, especially alopecia totalis. This study emphasizes the role of the differentiating anagen keratinocytes as an important structure in the autoimmune etiology of alopecia, both in APS I and at least in a subgroup of patients with alopecia areata unrelated to APS I.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594751     DOI: 10.1046/j.1523-1747.1999.00778.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Screening for associated autoimmune disorders in Polish patients with Addison's disease.

Authors:  Marta Fichna; Piotr Fichna; Maria Gryczyńska; Jarosław Walkowiak; Magdalena Zurawek; Jerzy Sowiński
Journal:  Endocrine       Date:  2010-03-16       Impact factor: 3.633

2.  Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing.

Authors:  Enas A S Attia; Dina El Shennawy; Ashraf Sefin
Journal:  Dermatol Res Pract       Date:  2010-06-30

3.  The immune response to melanoma is limited by thymic selection of self-antigens.

Authors:  Ulrike Träger; Sophie Sierro; Gordana Djordjevic; Basma Bouzo; Shivani Khandwala; Antonella Meloni; Monika Mortensen; Anna Katharina Simon
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

4.  Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients.

Authors:  Hassan Seyrafi; Maryam Akhiani; Hamed Abbasi; Sahar Mirpour; Ali Gholamrezanezhad
Journal:  BMC Dermatol       Date:  2005-10-31

5.  Whole exome sequencing in Alopecia Areata identifies rare variants in KRT82.

Authors:  Stephanie O Erjavec; Sahar Gelfman; Alexa R Abdelaziz; Eunice Y Lee; Isha Monga; Anna Alkelai; Iuliana Ionita-Laza; Lynn Petukhova; Angela M Christiano
Journal:  Nat Commun       Date:  2022-02-10       Impact factor: 14.919

Review 6.  Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications.

Authors:  Shahnawaz D Jadeja; Desmond J Tobin
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

7.  A novel AIRE gene mutation in a patient with autoimmune polyendocrinopathy candidiasis and ectodermal dystrophy revealed by alopecia areata.

Authors:  Aycha Arousse; Lobna Boussofara; Dorra H'mida-Ben Brahim; Mélanie Migaud; Amina Aounallah; Najet Ghariani; Jean-Laurent Casanova; Rafiaa Nouira; Anne Puel; Mohamed Denguezli
Journal:  JAAD Case Rep       Date:  2018-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.